DrugPatentWatch Database Preview
SERPASIL-ESIDRIX Drug Profile
When do Serpasil-esidrix patents expire, and what generic alternatives are available?
The generic ingredient in SERPASIL-ESIDRIX is hydrochlorothiazide; reserpine. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; reserpine profile page.
Summary for SERPASIL-ESIDRIX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | SERPASIL-ESIDRIX at DailyMed |
US Patents and Regulatory Information for SERPASIL-ESIDRIX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | SERPASIL-ESIDRIX #1 | hydrochlorothiazide; reserpine | TABLET;ORAL | 011878-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Novartis | SERPASIL-ESIDRIX #2 | hydrochlorothiazide; reserpine | TABLET;ORAL | 011878-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
